Are there health concerns with low ALT?

While low ALT levels are generally not concerning and often indicate good liver health, extremely low levels may occasionally signal nutritional deficiencies or rare genetic conditions. Most people with low ALT have no health issues, but persistent levels below 10 U/L warrant discussion with a healthcare provider.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding ALT and Its Role in Your Body

Alanine aminotransferase (ALT) is an enzyme found primarily in liver cells, with smaller amounts in the kidneys, heart, and muscles. This enzyme plays a crucial role in amino acid metabolism, helping convert alanine into pyruvate, which your body uses for energy production. When liver cells are damaged or inflamed, ALT leaks into the bloodstream, making it a valuable biomarker for liver health assessment.

Healthcare providers typically focus on elevated ALT levels as they often indicate liver damage, inflammation, or disease. However, some people may have ALT levels that fall below the normal range, leading to questions about whether low ALT is a cause for concern. Understanding what low ALT means and its potential implications can help you make informed decisions about your health.

What Are Normal ALT Levels?

Normal ALT levels vary slightly between laboratories and can differ based on sex and age. Generally, the reference ranges are:

ALT Level Interpretation Guide

ALT levels should be interpreted alongside other liver function tests and clinical symptoms for accurate assessment.
ALT Level (U/L)CategoryClinical SignificanceRecommended Action
Below 5<5 U/LVery LowMay indicate B6 deficiency or frailty in elderlyDiscuss with healthcare provider
5-105-10 U/LLowUsually normal variant, rarely concerningMonitor if symptomatic
7-55 (men) / 7-45 (women)Normal rangeNormalHealthy liver functionRoutine monitoring only
Above normal>55 (men) / >45 (women)ElevatedPossible liver inflammation or damageFurther evaluation needed

ALT levels should be interpreted alongside other liver function tests and clinical symptoms for accurate assessment.

  • Men: 7-55 units per liter (U/L)
  • Women: 7-45 U/L
  • Children: May have slightly different ranges depending on age

Low ALT is typically defined as levels below 7-10 U/L, though some laboratories may use different cutoff values. It's important to note that these reference ranges are statistical averages, and individual variations exist. Some people naturally have ALT levels at the lower end of the spectrum without any underlying health issues.

Is Low ALT Actually a Problem?

In most cases, low ALT levels are not a cause for concern. Unlike elevated ALT, which often signals liver damage or disease, low ALT typically indicates that your liver cells are healthy and not releasing excess enzymes into your bloodstream. Many people with low ALT levels have no symptoms and lead perfectly healthy lives.

However, extremely low ALT levels (particularly below 5 U/L) may occasionally warrant further investigation. While rare, persistently low ALT can sometimes be associated with certain conditions or deficiencies that affect enzyme production or function. The key is understanding the context of your overall health and whether you're experiencing any symptoms.

When Low ALT Might Be Significant

Research suggests that very low ALT levels might be meaningful in specific contexts. A study published in the Journal of Clinical Medicine found that elderly individuals with extremely low ALT levels had increased frailty and mortality risk. However, this association was primarily observed in older adults and may not apply to younger, healthy individuals.

Potential Causes of Low ALT Levels

Several factors can contribute to lower than normal ALT levels. Understanding these causes can help you and your healthcare provider determine whether further evaluation is necessary.

Nutritional Deficiencies

Vitamin B6 (pyridoxine) deficiency is one of the most common causes of low ALT levels. This vitamin serves as a cofactor for ALT enzyme function, meaning the enzyme cannot work properly without adequate B6. People with poor dietary intake, malabsorption disorders, or certain medications that interfere with B6 metabolism may develop this deficiency.

Other nutritional factors that may contribute to low ALT include:

  • Protein malnutrition
  • Severe caloric restriction
  • Malabsorption syndromes affecting nutrient uptake

Genetic Factors

Some individuals naturally produce less ALT due to genetic variations. These genetic differences are usually benign and don't cause health problems. Certain rare genetic conditions affecting amino acid metabolism might also result in lower ALT production, though these conditions typically present with other more prominent symptoms.

ALT levels tend to decrease with age, particularly in elderly individuals. This decline may reflect reduced muscle mass, changes in liver size, or altered metabolic processes. While this age-related decrease is generally normal, extremely low levels in older adults may indicate frailty or increased health risks.

Upload your blood test results to track your progress

Seamlessly upload 3rd party biomarker & blood tests to track your whole health in 1 dashboard. Understand what each blood test means and how it fits into the bigger picture of your body and health.

Get diet and lifestyle recommendations based on your blood results, health profile and health goals. You'll also receive a custom supplement recommendation for the precise nutrients your body craves.

Upload Past Blood Test Results

Click or drag file to upload

Once you upload your report, we'll extract the results for your review. Works with top labs including Quest Diagnostics, LabCorp, BioReference, EverlyWell, LetsGetChecked and hundreds of other labs.

Health Conditions Associated with Low ALT

While low ALT itself rarely causes symptoms, certain conditions may present with low ALT as one of several laboratory findings:

Chronic Kidney Disease

Some studies have found associations between low ALT levels and chronic kidney disease, particularly in patients undergoing dialysis. The exact mechanism isn't fully understood but may relate to altered protein metabolism or nutritional status in kidney disease patients.

Sarcopenia and Frailty

Low ALT levels have been linked to sarcopenia (age-related muscle loss) and frailty syndrome in elderly populations. Since ALT is also present in muscle tissue, reduced muscle mass may contribute to lower circulating ALT levels. This association highlights the importance of maintaining muscle mass and strength as we age.

Should You Be Concerned About Your Low ALT?

For most people, low ALT levels are not a cause for alarm. Consider the following factors when evaluating your ALT results:

  • Your overall health status and presence of symptoms
  • Other liver function tests (AST, bilirubin, albumin)
  • Your age and nutritional status
  • Medications you're taking
  • Recent changes in diet or weight

If your ALT is mildly low (between 5-10 U/L) and you feel well with normal results on other tests, there's typically no need for concern. However, if your ALT is extremely low (below 5 U/L) or you're experiencing symptoms like fatigue, weakness, or unexplained weight loss, discussing these findings with your healthcare provider is advisable.

How to Monitor Your Liver Health Comprehensively

ALT is just one piece of the liver health puzzle. A comprehensive assessment includes multiple biomarkers that provide a complete picture of liver function. Regular monitoring can help detect potential issues early and track your liver health over time.

Key liver biomarkers to monitor include:

  • AST (Aspartate aminotransferase): Another liver enzyme that works alongside ALT
  • Bilirubin: Indicates how well your liver processes waste products
  • Albumin: Reflects your liver's protein production capacity
  • Alkaline phosphatase (ALP): Can indicate bile duct issues
  • GGT (Gamma-glutamyl transferase): Sensitive marker for liver disease

Addressing Low ALT Through Nutrition

If nutritional deficiency is suspected as the cause of low ALT, focusing on adequate nutrition can help normalize levels. Key nutritional strategies include:

Vitamin B6 Sources

Since B6 deficiency is the most common nutritional cause of low ALT, incorporating B6-rich foods can be beneficial:

  • Poultry (chicken, turkey)
  • Fish (salmon, tuna)
  • Chickpeas and legumes
  • Potatoes and sweet potatoes
  • Bananas
  • Fortified cereals

Protein Intake

Adequate protein consumption supports enzyme production and overall liver health. Aim for a balanced intake of high-quality protein sources throughout the day, including both animal and plant-based options. The recommended dietary allowance for protein is 0.8 grams per kilogram of body weight, though individual needs may vary.

When to Seek Medical Evaluation

While low ALT is usually benign, certain situations warrant medical evaluation:

  • ALT levels consistently below 5 U/L
  • Accompanying symptoms like chronic fatigue, weakness, or unexplained weight loss
  • Other abnormal liver function tests
  • Known nutritional deficiencies or malabsorption disorders
  • Recent significant changes in diet or health status

Your healthcare provider may recommend additional testing to rule out underlying conditions, assess nutritional status, or evaluate overall liver function. This might include vitamin B6 levels, comprehensive metabolic panel, or imaging studies if indicated.

The Bottom Line on Low ALT

Low ALT levels are generally not a cause for concern and often indicate healthy liver function. Unlike elevated ALT, which frequently signals liver damage, low ALT typically reflects the absence of liver cell injury. However, extremely low levels, particularly when accompanied by symptoms or other abnormal findings, may warrant further investigation.

The key to understanding your ALT results lies in considering them within the context of your overall health, other laboratory values, and any symptoms you may be experiencing. Regular monitoring of liver biomarkers, maintaining good nutrition, and staying physically active are excellent strategies for supporting optimal liver health throughout your life.

Remember that laboratory values are just one tool in assessing health. If you have concerns about your ALT levels or liver health, discussing them with a healthcare provider who can evaluate your individual situation is always the best approach. They can help determine whether any additional testing or interventions are necessary based on your unique health profile.

References

  1. Ramaty, E., Maor, E., Peltz-Sinvani, N., et al. (2014). Low ALT blood levels predict long-term all-cause mortality among adults. A historical prospective cohort study. European Journal of Internal Medicine, 25(10), 919-921.[Link][DOI]
  2. Le Couteur, D. G., Blyth, F. M., Creasey, H. M., et al. (2010). The association of alanine transaminase with aging, frailty, and mortality. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 65(7), 712-717.[PubMed][DOI]
  3. Elinav, E., Ben-Dov, I. Z., Ackerman, E., et al. (2005). Correlation between serum alanine aminotransferase activity and age: an inverted U curve pattern. American Journal of Gastroenterology, 100(10), 2201-2204.[PubMed][DOI]
  4. Lumeng, L., & Li, T. K. (1974). Vitamin B6 metabolism in chronic alcohol abuse. Pyridoxal phosphate levels in plasma and the effects of acetaldehyde on pyridoxal phosphate synthesis and degradation in human erythrocytes. Journal of Clinical Investigation, 53(3), 693-704.[PubMed][DOI]
  5. Ruhl, C. E., & Everhart, J. E. (2013). The association of low serum alanine aminotransferase activity with mortality in the US population. American Journal of Epidemiology, 178(12), 1702-1711.[PubMed][DOI]
  6. Vespasiani-Gentilucci, U., De Vincentis, A., Ferrucci, L., et al. (2018). Low alanine aminotransferase levels in the elderly population: Frailty, disability, sarcopenia, and reduced survival. Journal of Gerontology: Medical Sciences, 73(7), 925-930.[PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my ALT at home?

You can test your ALT at home with SiPhox Health's Heart & Metabolic Program, which includes ALT testing along with other liver function markers like AST, bilirubin, and albumin. This CLIA-certified program provides lab-quality results from the comfort of your home.

What is considered a dangerously low ALT level?

While there's no universally agreed upon 'dangerous' low ALT level, values consistently below 5 U/L may warrant investigation, especially if accompanied by symptoms. Most people with ALT levels between 5-10 U/L have no health issues.

Can vitamin supplements help raise low ALT levels?

If low ALT is due to vitamin B6 deficiency, supplementation can help normalize levels. However, it's important to identify the underlying cause first. A typical B6 supplement dose ranges from 1.3-1.7 mg daily for adults, but consult your healthcare provider before starting supplements.

How often should I check my ALT levels?

For most healthy individuals, annual testing is sufficient. If you have low ALT levels without symptoms, your doctor may recommend rechecking in 6-12 months. Those with liver conditions or risk factors may need more frequent monitoring, typically every 3-6 months.

Can low ALT levels affect my energy or metabolism?

Low ALT itself doesn't directly cause fatigue or metabolic issues. However, if low ALT is due to nutritional deficiencies or underlying conditions, you might experience related symptoms. Extremely low ALT in elderly individuals has been associated with frailty and reduced energy.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details